Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
115.93
-1.20 (-1.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.64B in the quarter ending September 30, 2024, with 4.85% growth. This brings the company's revenue in the last twelve months to $41.22B, up 3.15% year-over-year. In the year 2023, Abbott Laboratories had annual revenue of $40.11B, down -8.12%.
Revenue (ttm)
$41.22B
Revenue Growth
+3.15%
P/S Ratio
4.90
Revenue / Employee
$361,553
Employees
114,000
Market Cap
201.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | 31.90B | 1.33B | 4.34% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher | 42.37B |
Novo Nordisk | 40.47B |
Amgen | 32.53B |
ABT News
- 14 days ago - Abbott India posts Q2 profit rise on strong demand, price hikes - Reuters
- 19 days ago - Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win - Investopedia
- 20 days ago - Abbott shares rise after securing first win in premature infant formula trial - Reuters
- 20 days ago - Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling - Market Watch
- 20 days ago - Abbott, Reckitt cleared of liability in latest preterm formula case - Reuters
- 21 days ago - Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead - Reuters
- 22 days ago - My Best Dividend Aristocrats For November 2024 - Seeking Alpha
- 23 days ago - Tidepool Will Integrate With Abbott's FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud Data - Business Wire